External Validation os the ACME Scoring System
ConditionAcute Cholecystitis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHospital del Mar
About this trial
Acute calculous cholecystitis (ACC) is the second most frequent surgical condition in emergency departments. The recommended treatment is surgical treatment (ST) and the accepted mortality is \<1%, but in severe and/or fragile patients is higher. Despite the Tokyo Guidelines, there no consensus on who is the unfit patient for ST. A recent study has identified 4 risk factors that predicts the mortality in a 92% of patients (ACME) and could help to develop new guidelines in ACC. The aim of this study is to perfom an external validation of the new simplified scoring system for mortality in ACC.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Acute Calculous Cholecystitis
Disqualifiers
Acute Cholangitis
Chronic Cholecystitis
Neoplasia
Acute Pancreatitis
Trial population
All the consecutive admisions with an acute calculous cholecystitis, independent on the treatment indicated, during 2025 and 2026.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Mortality
Describe the mortality in the cohort and its causes
Time frame
Jan 2025- Dec 20262
Complications
Describe the mortality in the cohort by Clavien-Dindo's classification
Time frame
Jan 2025- Dec 20263
ACME's prediction of mortality
To describe the prediction in a ROC Curve of ACME Scoring System with C-Statistic
Time frame
Jan 2025- Dec 2026Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: